Abstract
Recently, noninvasive brain stimulation (NIBS) methodologies, including TMS and tDCS, have been considered as efficacious, safe, and innovative treatments and alternatives to conventional therapies for some psychiatric disorders. Developing evidence suggests that applying rTMS and tDCS over the cognitive control network (CCN), particularly the dorsolateral prefrontal cortex (DLPFC), may improve core symptoms in various psychiatric disorders via direct impact on the cognitive control processes involved in emotion regulation. Therefore, neuromodulation of brain regions involved in the cognitive control of emotion by NIBS approaches could contribute to a paradigm shift in psychiatry. The available evidence suggests that development of effective treatment alternatives to enhance cognition is critical for patients with psychiatric disorders. The purpose of this chapter is to review the cognition-enhancing properties of tDCS and TMS and the impact of these treatments on cognitive control processes, especially those related to emotion regulation in psychiatric disorders.
| Original language | English |
|---|---|
| Title of host publication | Advances in Experimental Medicine and Biology |
| Publisher | Springer New York LLC |
| Pages | 545-564 |
| Number of pages | 20 |
| DOIs | |
| Publication status | Published - 2019 |
Publication series
| Name | Advances in Experimental Medicine and Biology |
|---|---|
| Volume | 1192 |
| ISSN (Print) | 0065-2598 |
| ISSN (Electronic) | 2214-8019 |
Bibliographical note
Publisher Copyright:© Springer Nature Singapore Pte Ltd. 2019.
Keywords
- Cognition
- Neuromodulation
- Paradigm shift
- Psychiatric disorders
- TMS
- tDCS
ASJC Scopus subject areas
- General Biochemistry,Genetics and Molecular Biology